Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-06

AUTHORS

Jean-Luc Faillie, Samy Babai, Sabrina Crépin, Virginie Bres, Marie-Laure Laroche, Hervé Le Louet, Pierre Petit, Jean-Louis Montastruc, Dominique Hillaire-Buys, The French Pharmacovigilance Centers Network

ABSTRACT

In the recent past, concerns have raised regarding the potential risk of acute pancreatitis among type 2 diabetic patients using incretin-based drugs such as glucagon-like peptide 1 (GLP-1) analogs and dipeptidyl peptidase 4 (DPP-4) inhibitors. The aim of this study is to investigate the association between exposure to incretin-based drugs and the occurrence of pancreatitis reported in the French Pharmacovigilance Database. The case/non-case method was performed from serious adverse drug reactions (ADRs) involving antihyperglycemic agents (except insulin alone) reported to the French pharmacovigilance system between March 2008 (first marketing of an incretin-based drug in France) and March 2013. Cases were defined as reports of pancreatitis, and all other serious ADRs were considered non-cases. Disproportionality was assessed by calculating reporting odds ratios (ROR) adjusted for age, gender, history of pancreatitis, other antihyperglycemic drugs and other drugs associated with a higher risk of pancreatitis. Among 3,109 serious ADRs, 147 (4.7 %) reports of pancreatitis were identified as cases and 2,962 reports (95.3 %) of other ADRs as non-cases. Among the cases, 122 (83.0 %) involved incretin-based drugs. Disproportionality was found for all incretin-based drugs (adjusted ROR: 15.7 [95 % CI 9.8-24.9]), all GLP-1 analogs (29.4 [16.0-53.8]), exenatide (28.3 [12.8-62.3]), liraglutide (30.4 [15.4-60.0]), all DPP-4 inhibitors (12.1 [7.3-20.0]), sitagliptin (12.4 [7.3-21.0]), saxagliptin (15.1 [4.3-52.7]), and vildagliptin (7.4 [3.1-17.6]). Temporal analysis found disproportionality for incretin-based drugs since their first year of marketing in France. Compared with other antihyperglycemic agents, use of incretin-based drugs is associated with an increased risk of reported pancreatitis in France. More... »

PAGES

491-497

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00592-013-0544-0

DOI

http://dx.doi.org/10.1007/s00592-013-0544-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1039851598

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24352344


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dipeptidyl-Peptidase IV Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucagon-Like Peptide 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreatitis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmacovigilance", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHRU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France", 
            "Department of Pharmacoepidemiology, Faculty of Medicine, INSERM U1027, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Faillie", 
        "givenName": "Jean-Luc", 
        "id": "sg:person.0646700416.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646700416.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Pharmacovigilance Regional Center, CHU Cr\u00e9teil, Cr\u00e9teil, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Babai", 
        "givenName": "Samy", 
        "id": "sg:person.0672042653.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672042653.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Limoges", 
          "id": "https://www.grid.ac/institutes/grid.411178.a", 
          "name": [
            "Department of Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHU Limoges, Limoges, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cr\u00e9pin", 
        "givenName": "Sabrina", 
        "id": "sg:person.01142334376.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142334376.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHRU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bres", 
        "givenName": "Virginie", 
        "id": "sg:person.01245024632.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245024632.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Limoges", 
          "id": "https://www.grid.ac/institutes/grid.411178.a", 
          "name": [
            "Department of Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHU Limoges, Limoges, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laroche", 
        "givenName": "Marie-Laure", 
        "id": "sg:person.0657215621.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657215621.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Pharmacovigilance Regional Center, CHU Cr\u00e9teil, Cr\u00e9teil, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Louet", 
        "givenName": "Herv\u00e9", 
        "id": "sg:person.01352351755.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352351755.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHRU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petit", 
        "givenName": "Pierre", 
        "id": "sg:person.01047375326.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047375326.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Department of Medical and Clinical Pharmacology, Pharmacovigilance Regional Center, CHU Toulouse, Toulouse, France", 
            "Department of Pharmacoepidemiology, Faculty of Medicine, INSERM U1027, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montastruc", 
        "givenName": "Jean-Louis", 
        "id": "sg:person.01275357622.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275357622.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital of Montpellier", 
          "id": "https://www.grid.ac/institutes/grid.157868.5", 
          "name": [
            "Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHRU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France", 
            "Faculty of Medicine, INSERM U1058, Montpellier, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hillaire-Buys", 
        "givenName": "Dominique", 
        "id": "sg:person.01333453573.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333453573.34"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "The French Pharmacovigilance Centers Network", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1997.00615.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000690843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1307684", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003605360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc10-0842", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003657685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200730100-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005348063", 
          "https://doi.org/10.2165/00002018-200730100-00007"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/03007990902820519", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007161043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamainternmed.2013.2720", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007888717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-013-0024-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008952853", 
          "https://doi.org/10.1007/s13300-013-0024-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200831100-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011019134", 
          "https://doi.org/10.2165/00002018-200831100-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200629050-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012106416", 
          "https://doi.org/10.2165/00002018-200629050-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1742", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015083994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1742", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015083994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db13-0822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015119869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2010.01231.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017805765"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2010.01231.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017805765"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1305889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018262898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00592-011-0340-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020378910", 
          "https://doi.org/10.1007/s00592-011-0340-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.f2267", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021890392"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc10-0482", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023124322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2011.04037.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023230874"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.2003.01968.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023633070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.d2335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026407719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.diabres.2012.09.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026849441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14740338.4.5.929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029592816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14740338.4.5.929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029592816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-008-0497-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030890998", 
          "https://doi.org/10.1007/s00228-008-0497-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-008-0497-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030890998", 
          "https://doi.org/10.1007/s00228-008-0497-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200528100-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032498547", 
          "https://doi.org/10.2165/00002018-200528100-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200528100-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032498547", 
          "https://doi.org/10.2165/00002018-200528100-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2012.03652.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036159506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2011.02.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039062889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.f2607", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040076268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.1157", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040359880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc08-1755", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043821067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2504", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045011693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db13-0520", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045421438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db12-1686", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046692384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/db09-0058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047627029"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1463-1326.2011.01376.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050696100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc12-2713", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051850491"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/dia.2012.0075", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059249680"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-06", 
    "datePublishedReg": "2014-06-01", 
    "description": "In the recent past, concerns have raised regarding the potential risk of acute pancreatitis among type 2 diabetic patients using incretin-based drugs such as glucagon-like peptide 1 (GLP-1) analogs and dipeptidyl peptidase 4 (DPP-4) inhibitors. The aim of this study is to investigate the association between exposure to incretin-based drugs and the occurrence of pancreatitis reported in the French Pharmacovigilance Database. The case/non-case method was performed from serious adverse drug reactions\u00a0(ADRs) involving antihyperglycemic agents (except insulin alone) reported to the French pharmacovigilance system between March 2008 (first marketing of an incretin-based drug in France) and March 2013. Cases were defined as reports of pancreatitis, and all other serious ADRs were considered non-cases. Disproportionality was assessed by calculating reporting odds ratios (ROR) adjusted for age, gender, history of pancreatitis, other antihyperglycemic drugs and other drugs associated with a higher risk of pancreatitis. Among 3,109 serious ADRs, 147 (4.7\u00a0%) reports of pancreatitis were identified as cases and 2,962 reports (95.3\u00a0%) of other ADRs as non-cases. Among the cases, 122 (83.0\u00a0%) involved incretin-based drugs. Disproportionality was found for all incretin-based drugs (adjusted ROR: 15.7 [95\u00a0% CI 9.8-24.9]), all GLP-1 analogs (29.4 [16.0-53.8]), exenatide (28.3 [12.8-62.3]), liraglutide (30.4 [15.4-60.0]), all DPP-4 inhibitors (12.1 [7.3-20.0]), sitagliptin (12.4 [7.3-21.0]), saxagliptin (15.1 [4.3-52.7]), and vildagliptin (7.4 [3.1-17.6]). Temporal analysis found disproportionality for incretin-based drugs since their first year of marketing in France. Compared with other antihyperglycemic agents, use of incretin-based drugs is associated with an increased risk of reported pancreatitis in France. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00592-013-0544-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1008525", 
        "issn": [
          "0940-5429", 
          "1432-5233"
        ], 
        "name": "Acta Diabetologica", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "51"
      }
    ], 
    "name": "Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database", 
    "pagination": "491-497", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "bdd5a6122bfb0f01b7e7fd5257af55633b568d1ed860eec50fd8c154cff193f1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24352344"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9200299"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00592-013-0544-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1039851598"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00592-013-0544-0", 
      "https://app.dimensions.ai/details/publication/pub.1039851598"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000514.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00592-013-0544-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00592-013-0544-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00592-013-0544-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00592-013-0544-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00592-013-0544-0'


 

This table displays all metadata directly associated to this object as RDF triples.

314 TRIPLES      21 PREDICATES      79 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00592-013-0544-0 schema:about N3a6906076ed5483390580aba206485e3
2 N3fc85fed1cf9443580fba1580aa0517c
3 N55c71b37f8d94636bd7934cb40bd34b1
4 N57537b7c12b8494385dad87bcfcbddb6
5 N598259ab7e58463b9f96c16462879996
6 N75c9e47589bf4897bc4ba46fd0c6c2dd
7 N7d19cb38d3d147ffa083b973cd68e1d6
8 N8c59653becdc46ae8a2839b81256b71a
9 Na496d0c7aeb8498fbbdf5f912b924cbf
10 Na8e09f47cb9746bbac1235fa66339d84
11 Nc33a6ab26a5d42bbaefb284affb1ea23
12 Ncc3f9ac6505d4f0eb56b91acae1eac51
13 Ndc46c73a0a7240c2bf4c7d58fe379aa1
14 Nf24487819bc94d3d8a4b1779e3c6e66e
15 Nf71a68d8ff6346bdbde0a4fae6f86b6c
16 anzsrc-for:11
17 anzsrc-for:1103
18 schema:author Na325d71b99884b6e9908e170cdfa9636
19 schema:citation sg:pub.10.1007/s00228-008-0497-3
20 sg:pub.10.1007/s00592-011-0340-7
21 sg:pub.10.1007/s13300-013-0024-0
22 sg:pub.10.2165/00002018-200528100-00001
23 sg:pub.10.2165/00002018-200629050-00003
24 sg:pub.10.2165/00002018-200730100-00007
25 sg:pub.10.2165/00002018-200831100-00002
26 https://doi.org/10.1001/jamainternmed.2013.2720
27 https://doi.org/10.1002/pds.1742
28 https://doi.org/10.1002/sim.1157
29 https://doi.org/10.1016/j.diabres.2012.09.008
30 https://doi.org/10.1046/j.1365-2125.1997.00615.x
31 https://doi.org/10.1046/j.1365-2125.2003.01968.x
32 https://doi.org/10.1053/j.gastro.2011.02.018
33 https://doi.org/10.1056/nejmoa1305889
34 https://doi.org/10.1056/nejmoa1307684
35 https://doi.org/10.1089/dia.2012.0075
36 https://doi.org/10.1111/j.1365-2125.2011.04037.x
37 https://doi.org/10.1111/j.1463-1326.2010.01231.x
38 https://doi.org/10.1111/j.1463-1326.2011.01376.x
39 https://doi.org/10.1111/j.1464-5491.2012.03652.x
40 https://doi.org/10.1136/bmj.d2335
41 https://doi.org/10.1136/bmj.f2267
42 https://doi.org/10.1136/bmj.f2607
43 https://doi.org/10.1185/03007990902820519
44 https://doi.org/10.1517/14740338.4.5.929
45 https://doi.org/10.2337/db09-0058
46 https://doi.org/10.2337/db12-1686
47 https://doi.org/10.2337/db13-0520
48 https://doi.org/10.2337/db13-0822
49 https://doi.org/10.2337/dc08-1755
50 https://doi.org/10.2337/dc10-0482
51 https://doi.org/10.2337/dc10-0842
52 https://doi.org/10.2337/dc12-2504
53 https://doi.org/10.2337/dc12-2713
54 schema:datePublished 2014-06
55 schema:datePublishedReg 2014-06-01
56 schema:description In the recent past, concerns have raised regarding the potential risk of acute pancreatitis among type 2 diabetic patients using incretin-based drugs such as glucagon-like peptide 1 (GLP-1) analogs and dipeptidyl peptidase 4 (DPP-4) inhibitors. The aim of this study is to investigate the association between exposure to incretin-based drugs and the occurrence of pancreatitis reported in the French Pharmacovigilance Database. The case/non-case method was performed from serious adverse drug reactions (ADRs) involving antihyperglycemic agents (except insulin alone) reported to the French pharmacovigilance system between March 2008 (first marketing of an incretin-based drug in France) and March 2013. Cases were defined as reports of pancreatitis, and all other serious ADRs were considered non-cases. Disproportionality was assessed by calculating reporting odds ratios (ROR) adjusted for age, gender, history of pancreatitis, other antihyperglycemic drugs and other drugs associated with a higher risk of pancreatitis. Among 3,109 serious ADRs, 147 (4.7 %) reports of pancreatitis were identified as cases and 2,962 reports (95.3 %) of other ADRs as non-cases. Among the cases, 122 (83.0 %) involved incretin-based drugs. Disproportionality was found for all incretin-based drugs (adjusted ROR: 15.7 [95 % CI 9.8-24.9]), all GLP-1 analogs (29.4 [16.0-53.8]), exenatide (28.3 [12.8-62.3]), liraglutide (30.4 [15.4-60.0]), all DPP-4 inhibitors (12.1 [7.3-20.0]), sitagliptin (12.4 [7.3-21.0]), saxagliptin (15.1 [4.3-52.7]), and vildagliptin (7.4 [3.1-17.6]). Temporal analysis found disproportionality for incretin-based drugs since their first year of marketing in France. Compared with other antihyperglycemic agents, use of incretin-based drugs is associated with an increased risk of reported pancreatitis in France.
57 schema:genre research_article
58 schema:inLanguage en
59 schema:isAccessibleForFree false
60 schema:isPartOf N2f7baf8b56654eee95bd830dd9830af6
61 N40dafa80914843ffaa5b56f37458f79e
62 sg:journal.1008525
63 schema:name Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database
64 schema:pagination 491-497
65 schema:productId N28f5e1e44c4045d6a91ad0cd26308f13
66 N5758a2593b5e4895b28335f6ed751ed1
67 N86aa46e7b5c84c9fb0873396b4143a3b
68 N9d7925db96374775a5bda61a87376c81
69 Nad573364f9d447b2ac757c9ddfca90c2
70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039851598
71 https://doi.org/10.1007/s00592-013-0544-0
72 schema:sdDatePublished 2019-04-11T00:16
73 schema:sdLicense https://scigraph.springernature.com/explorer/license/
74 schema:sdPublisher N83d31bf2132a42a19372e7793b1e26aa
75 schema:url http://link.springer.com/10.1007%2Fs00592-013-0544-0
76 sgo:license sg:explorer/license/
77 sgo:sdDataset articles
78 rdf:type schema:ScholarlyArticle
79 N02cadadff59d43faa33dfe44aa82a8a4 rdf:first sg:person.01047375326.28
80 rdf:rest Nd0ffee8b0960490db8c8d19b978e6ca6
81 N23e88e393fa4497da71f85b648ccc421 rdf:first N2df368459ccd4ae6bb169ef5ccc0c917
82 rdf:rest rdf:nil
83 N28f5e1e44c4045d6a91ad0cd26308f13 schema:name dimensions_id
84 schema:value pub.1039851598
85 rdf:type schema:PropertyValue
86 N2df368459ccd4ae6bb169ef5ccc0c917 schema:familyName The French Pharmacovigilance Centers Network
87 rdf:type schema:Person
88 N2f7baf8b56654eee95bd830dd9830af6 schema:volumeNumber 51
89 rdf:type schema:PublicationVolume
90 N3a6906076ed5483390580aba206485e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Pancreatitis
92 rdf:type schema:DefinedTerm
93 N3fc85fed1cf9443580fba1580aa0517c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Aged, 80 and over
95 rdf:type schema:DefinedTerm
96 N40dafa80914843ffaa5b56f37458f79e schema:issueNumber 3
97 rdf:type schema:PublicationIssue
98 N54efff2408654b30b06938e574ccd298 rdf:first sg:person.01333453573.34
99 rdf:rest N23e88e393fa4497da71f85b648ccc421
100 N55c71b37f8d94636bd7934cb40bd34b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Diabetes Mellitus, Type 2
102 rdf:type schema:DefinedTerm
103 N57537b7c12b8494385dad87bcfcbddb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Pharmacovigilance
105 rdf:type schema:DefinedTerm
106 N5758a2593b5e4895b28335f6ed751ed1 schema:name nlm_unique_id
107 schema:value 9200299
108 rdf:type schema:PropertyValue
109 N598259ab7e58463b9f96c16462879996 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Case-Control Studies
111 rdf:type schema:DefinedTerm
112 N5e6bfb448eef431ca4f5e5f09175fcae schema:name Pharmacovigilance Regional Center, CHU Créteil, Créteil, France
113 rdf:type schema:Organization
114 N75c9e47589bf4897bc4ba46fd0c6c2dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Adult
116 rdf:type schema:DefinedTerm
117 N7d19cb38d3d147ffa083b973cd68e1d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Glucagon-Like Peptide 1
119 rdf:type schema:DefinedTerm
120 N83d31bf2132a42a19372e7793b1e26aa schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 N86aa46e7b5c84c9fb0873396b4143a3b schema:name doi
123 schema:value 10.1007/s00592-013-0544-0
124 rdf:type schema:PropertyValue
125 N8c59653becdc46ae8a2839b81256b71a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 N960380489fc4464db81d713d680e6c5f rdf:first sg:person.0657215621.97
129 rdf:rest Nfbb95ea674c3489dad4a244f58c50e5a
130 N9d7925db96374775a5bda61a87376c81 schema:name readcube_id
131 schema:value bdd5a6122bfb0f01b7e7fd5257af55633b568d1ed860eec50fd8c154cff193f1
132 rdf:type schema:PropertyValue
133 Na0ea2c48c7e94c15855b164185044659 rdf:first sg:person.01245024632.48
134 rdf:rest N960380489fc4464db81d713d680e6c5f
135 Na325d71b99884b6e9908e170cdfa9636 rdf:first sg:person.0646700416.27
136 rdf:rest Nc52770f67df044568c492826b344b7b7
137 Na496d0c7aeb8498fbbdf5f912b924cbf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Databases, Factual
139 rdf:type schema:DefinedTerm
140 Na8e09f47cb9746bbac1235fa66339d84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Dipeptidyl-Peptidase IV Inhibitors
142 rdf:type schema:DefinedTerm
143 Nad573364f9d447b2ac757c9ddfca90c2 schema:name pubmed_id
144 schema:value 24352344
145 rdf:type schema:PropertyValue
146 Nb3462e8347bf47e29bcc69fc4e9b12a4 rdf:first sg:person.01142334376.35
147 rdf:rest Na0ea2c48c7e94c15855b164185044659
148 Nc33a6ab26a5d42bbaefb284affb1ea23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Aged
150 rdf:type schema:DefinedTerm
151 Nc52770f67df044568c492826b344b7b7 rdf:first sg:person.0672042653.84
152 rdf:rest Nb3462e8347bf47e29bcc69fc4e9b12a4
153 Ncc3f9ac6505d4f0eb56b91acae1eac51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Female
155 rdf:type schema:DefinedTerm
156 Nd0ffee8b0960490db8c8d19b978e6ca6 rdf:first sg:person.01275357622.51
157 rdf:rest N54efff2408654b30b06938e574ccd298
158 Nd7e1d65a0af04aba82d8973a99de219e schema:name Pharmacovigilance Regional Center, CHU Créteil, Créteil, France
159 rdf:type schema:Organization
160 Ndc46c73a0a7240c2bf4c7d58fe379aa1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Humans
162 rdf:type schema:DefinedTerm
163 Nf24487819bc94d3d8a4b1779e3c6e66e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Male
165 rdf:type schema:DefinedTerm
166 Nf71a68d8ff6346bdbde0a4fae6f86b6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name France
168 rdf:type schema:DefinedTerm
169 Nfbb95ea674c3489dad4a244f58c50e5a rdf:first sg:person.01352351755.14
170 rdf:rest N02cadadff59d43faa33dfe44aa82a8a4
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
175 schema:name Clinical Sciences
176 rdf:type schema:DefinedTerm
177 sg:journal.1008525 schema:issn 0940-5429
178 1432-5233
179 schema:name Acta Diabetologica
180 rdf:type schema:Periodical
181 sg:person.01047375326.28 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
182 schema:familyName Petit
183 schema:givenName Pierre
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047375326.28
185 rdf:type schema:Person
186 sg:person.01142334376.35 schema:affiliation https://www.grid.ac/institutes/grid.411178.a
187 schema:familyName Crépin
188 schema:givenName Sabrina
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142334376.35
190 rdf:type schema:Person
191 sg:person.01245024632.48 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
192 schema:familyName Bres
193 schema:givenName Virginie
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245024632.48
195 rdf:type schema:Person
196 sg:person.01275357622.51 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
197 schema:familyName Montastruc
198 schema:givenName Jean-Louis
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275357622.51
200 rdf:type schema:Person
201 sg:person.01333453573.34 schema:affiliation https://www.grid.ac/institutes/grid.157868.5
202 schema:familyName Hillaire-Buys
203 schema:givenName Dominique
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333453573.34
205 rdf:type schema:Person
206 sg:person.01352351755.14 schema:affiliation Nd7e1d65a0af04aba82d8973a99de219e
207 schema:familyName Le Louet
208 schema:givenName Hervé
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352351755.14
210 rdf:type schema:Person
211 sg:person.0646700416.27 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
212 schema:familyName Faillie
213 schema:givenName Jean-Luc
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646700416.27
215 rdf:type schema:Person
216 sg:person.0657215621.97 schema:affiliation https://www.grid.ac/institutes/grid.411178.a
217 schema:familyName Laroche
218 schema:givenName Marie-Laure
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657215621.97
220 rdf:type schema:Person
221 sg:person.0672042653.84 schema:affiliation N5e6bfb448eef431ca4f5e5f09175fcae
222 schema:familyName Babai
223 schema:givenName Samy
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672042653.84
225 rdf:type schema:Person
226 sg:pub.10.1007/s00228-008-0497-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030890998
227 https://doi.org/10.1007/s00228-008-0497-3
228 rdf:type schema:CreativeWork
229 sg:pub.10.1007/s00592-011-0340-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020378910
230 https://doi.org/10.1007/s00592-011-0340-7
231 rdf:type schema:CreativeWork
232 sg:pub.10.1007/s13300-013-0024-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008952853
233 https://doi.org/10.1007/s13300-013-0024-0
234 rdf:type schema:CreativeWork
235 sg:pub.10.2165/00002018-200528100-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032498547
236 https://doi.org/10.2165/00002018-200528100-00001
237 rdf:type schema:CreativeWork
238 sg:pub.10.2165/00002018-200629050-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012106416
239 https://doi.org/10.2165/00002018-200629050-00003
240 rdf:type schema:CreativeWork
241 sg:pub.10.2165/00002018-200730100-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005348063
242 https://doi.org/10.2165/00002018-200730100-00007
243 rdf:type schema:CreativeWork
244 sg:pub.10.2165/00002018-200831100-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011019134
245 https://doi.org/10.2165/00002018-200831100-00002
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1001/jamainternmed.2013.2720 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007888717
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1002/pds.1742 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015083994
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1002/sim.1157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040359880
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.diabres.2012.09.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026849441
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1046/j.1365-2125.1997.00615.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000690843
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1046/j.1365-2125.2003.01968.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023633070
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1053/j.gastro.2011.02.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039062889
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1056/nejmoa1305889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018262898
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1056/nejmoa1307684 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003605360
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1089/dia.2012.0075 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059249680
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1111/j.1365-2125.2011.04037.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023230874
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1111/j.1463-1326.2010.01231.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1017805765
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1111/j.1463-1326.2011.01376.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050696100
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1111/j.1464-5491.2012.03652.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036159506
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1136/bmj.d2335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026407719
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1136/bmj.f2267 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021890392
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1136/bmj.f2607 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040076268
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1185/03007990902820519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007161043
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1517/14740338.4.5.929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029592816
284 rdf:type schema:CreativeWork
285 https://doi.org/10.2337/db09-0058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047627029
286 rdf:type schema:CreativeWork
287 https://doi.org/10.2337/db12-1686 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046692384
288 rdf:type schema:CreativeWork
289 https://doi.org/10.2337/db13-0520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045421438
290 rdf:type schema:CreativeWork
291 https://doi.org/10.2337/db13-0822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015119869
292 rdf:type schema:CreativeWork
293 https://doi.org/10.2337/dc08-1755 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043821067
294 rdf:type schema:CreativeWork
295 https://doi.org/10.2337/dc10-0482 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023124322
296 rdf:type schema:CreativeWork
297 https://doi.org/10.2337/dc10-0842 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003657685
298 rdf:type schema:CreativeWork
299 https://doi.org/10.2337/dc12-2504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045011693
300 rdf:type schema:CreativeWork
301 https://doi.org/10.2337/dc12-2713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051850491
302 rdf:type schema:CreativeWork
303 https://www.grid.ac/institutes/grid.157868.5 schema:alternateName University Hospital of Montpellier
304 schema:name Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHRU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France
305 Faculty of Medicine, INSERM U1058, Montpellier, France
306 rdf:type schema:Organization
307 https://www.grid.ac/institutes/grid.411178.a schema:alternateName Centre Hospitalier Universitaire de Limoges
308 schema:name Department of Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHU Limoges, Limoges, France
309 rdf:type schema:Organization
310 https://www.grid.ac/institutes/grid.464120.5 schema:alternateName Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicaps
311 schema:name Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Center, CHRU Montpellier, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France
312 Department of Medical and Clinical Pharmacology, Pharmacovigilance Regional Center, CHU Toulouse, Toulouse, France
313 Department of Pharmacoepidemiology, Faculty of Medicine, INSERM U1027, Toulouse, France
314 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...